TAILIEUCHUNG - Pharmaceutical Substances Syntheses, Patents, Applications - Part 171

Pharmaceutical Substances Syntheses, Patents, Applications - Part 171. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers. | Prednylidene P 1701 prednisolone 17-volerote I 0 0 u u H3C 0 CH3 pyridine Reference s Gardi R. et al. Gazz. Chim. Ital. GCITA9 93 431 1963 . prednisolone 17-valerate DE 1 214 677 Francesco Vismara appl. I-prior. . US 3 147 249 Francesco Vismara I-prior. . cf. hydrocortisone butyrate betametasone valerate Trade Name s I Acepreval Parke Davis- Vister wfm Prednylidene ATC H02AB11 Use glucocorticoid RN 599-33-7 MF C22H28O5 MW EINECS 209-964-9 LDjo 7450 mg kg M . CN 11 P -l 1 17 21-trihydroxy-16-methylenepregna-l 4-diene-3 20-dione ii 1702 p Prednylidene diethylaminoacetate 16-methylenehydrocortisone ID Bacilllus sphaericus or Corynebacterium simplex Reference s DEI 134 074 E. Merck AG appl. . Mannhardt . et al. Tetrahedron Lett. TELEAY 1960 21. Taub D. et al. J. Org. Chem. JOCEAH 25 2258 I960 . alternative synthesis US 3 068 226 Merck Co. 1962 prior. 1961 1959 . Formulation s tabl. 6 mg 24 mg 60 mg . Trade Name s D Decortilen Merck I Dacortilen Merck Bracco F Décortilène Farmex wfm wfm Prednylidene diethylaminoacetate ATC H02AB11 Use glucocorticoid RN 6890-42-2 MF C2gH39NO6 MW CN AỤV-diethylglycine 1 lß -l l 17-dihydroxy-16-methylene-3 20-dioxopregna-l 4-dien-21-yl ester hydrochloride RN 22887-42-9 MF C28H39NO6 HC1 MW EINECS 245-299-0 Reference s DE 1 134 074 E. Merck AG appl. . combination with quinoline derivatives BE 829 197 Grosjean appl. . Formulationf s amp. 30 mg ml 60 mg ml Trade Name s D Decortilen sol. Merck Pregnenolone P 1703 Pregnenolone ATC L02BA Use glucocorticoid RN 145-13-1 MF C21H32O2 MW EINECS 205-647-4 CN 3 ß -3-hydroxypregn-5-en-20-one succinate RN 4598-67-8 MF C25H36O5 MW EINECS 225-001-5 acetate RN 1778-02-5 MF C23H34O3 MW EINECS 217-212-6 dehydropregnenolone ocetate H 1. H2 Pd 2. hydrolysis Reference s Ehrhart-Ruschig III 341. Ullmanns Encykl. Tech. Chem. 3. Aufl. Vol. 8 664 and there cited literature. .

• Sinh học
• 2267 hoạt chất dược phẩm
• Sách nghiên cứu dược
• hoạt chất dược phẩm
• tổng hợp quá trình sản xuất
• sáng chế thuốc